STA® - Liatest® D-Di 00515Recalls & reported problems
Diagnostica Stago · Class 2
Data updated Oct 16, 2026 from official FDA records · Editorial policy
2 open recalls name this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 0
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 2
Summary
No MAUDE adverse event reports in our data reference this device identifier directly.
2 FDA recall records name this device's identifier, 2 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Recalls naming this device
- Feb 5, 2026Open, Classified
After receiving customer complaints, investigations confirmed the presence of a positive bias in D-Dimer measurements throughout the entire analytical range.
Z-1585-2026 · Root cause: Process change control · Recall details · FDA record ↗
- Sep 12, 2025Open, Classified
A potential risk of underestimation of D-Dimer (D-Di) levels with the two listed lots.
Z-0205-2026 · Root cause: Under Investigation by firm · Recall details · FDA record ↗
Other FIBRINOGEN AND FIBRIN SPLIT PRODUCTS, ANTIGEN, ANTISERUM, CONTROL devices
- VIDAS® D-Dimer Exclusion II ™ 30455-01Biomerieux SA · Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control1 recall2 reports
- INNOVANCE® D-Dimer 10445981Siemens Healthcare Diagnostics Products GmbH · FIBRINOGEN AND FIBRIN SPLIT PRODUCTS, ANTIGEN, ANTISERUM, CONTROL9 reports
- INNOVANCE® D-Dimer 10445982Siemens Healthcare Diagnostics Products GmbH · FIBRINOGEN AND FIBRIN SPLIT PRODUCTS, ANTIGEN, ANTISERUM, CONTROL8 reports
- Alere Triage® 98100Alere San Diego, Inc. · Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control4 reports
- INNOVANCE® D-Dimer Controls 10446006Siemens Healthcare Diagnostics Products GmbH · FIBRINOGEN AND FIBRIN SPLIT PRODUCTS, ANTIGEN, ANTISERUM, CONTROL2 reports
- Triage 98100Quidel Cardiovascular Inc. · FIBRINOGEN AND FIBRIN SPLIT PRODUCTS, ANTIGEN, ANTISERUM, CONTROL1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page